Larimar Therapeutics, Inc. (LS:A2P5PP) IPO
IPO
Went public as ZAFGEN, INC. Priced at US$16.00 a share on Jun 18, 2014.
- Price
- US$16.00 a share
- Shares offered
- 6,000,000 shares of common stock
- Offering size
- US$96 million
- Underwriters' option
- Up to 900,000 more shares
- Underwriters
- Leerink Partners, Cowen and Company, Canaccord Genuity, JMP Securities · In the order on the cover
- Shares delivered
- On or about Jun 24, 2014
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Jan 31, 2014 |
| Filed publicly | Apr 18, 2014 |
| Amended 5 times | Newest Jun 16, 2014 |
| Shares registered with an exchange | Jun 18, 2014 |
| Declared effective by the SEC | Jun 18, 2014 |
| Final prospectus, with the price | Jun 19, 2014 |
Filings
| Filing | Filed |
|---|---|
| CORRESP · Letter to the SEC | Jun 20, 2014 |
| 424B4 · Prospectus | Jun 19, 2014 |
| EFFECT · Notice that a registration is effective | Jun 18, 2014 |
| S-1MEF · Registration of more shares for the same offering | Jun 18, 2014 |
| CERTNAS · Nasdaq's certificate of listing | Jun 18, 2014 |
| 8-A12B · Registration of shares for listing on an exchange | Jun 18, 2014 |
| CORRESP · Letter to the SEC | Jun 16, 2014 |
| CORRESP · Letter to the SEC | Jun 16, 2014 |
| S-1/A · Registration statement, amended | Jun 16, 2014 |
| S-1/A · Registration statement, amended | Jun 5, 2014 |
| S-1/A · Registration statement, amended | Jun 2, 2014 |
| S-1/A · Registration statement, amended | May 2, 2014 |
| S-1/A · Registration statement, amended | Apr 28, 2014 |
| S-1 · Registration statement | Apr 18, 2014 |
| UPLOAD · Letter from the SEC | Mar 27, 2014 |
| DRS/A · Draft registration statement, amended | Mar 14, 2014 |
| UPLOAD · Letter from the SEC | Feb 28, 2014 |
| DRS · Draft registration statement | Jan 31, 2014 |
From the cover of the final prospectus (424B4) filed Jun 19, 2014